drugset / Trial / NCT04524169
Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
Osteoporotic pain is the most common clinical symptom in elderly patients. The course of pain is prolonged and the effect of clinical treatment is limited. This study will observe the therapeutic effect of thymosin alpha 1 on elderly patient with osteoporotic pain and explore its immunotherapy mechanism.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymalfasin | Peptide | — | Subcutaneous |